Advertisement

Topics

Ongoing Trials Hope to Move DLBCL Field Beyond R-CHOP

16:15 EDT 14 Sep 2018 | OncLive

Cure rates in diffuse large B-cell lymphoma remain relatively unchanged, even following therapeutic additions to the armamentarium and an improved understanding of disease biology.

Original Article: Ongoing Trials Hope to Move DLBCL Field Beyond R-CHOP

NEXT ARTICLE

More From BioPortfolio on "Ongoing Trials Hope to Move DLBCL Field Beyond R-CHOP"

Advertisement
Quick Search
Advertisement
Advertisement